e.g. Tata motors, Reliance MF, 500570

Mangalam Drugs and Organics Ltd. - Research Center

532637 MANGALAM Group (T) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 318.23 368.59 372.25 451.07 380.14
Expenses
Material consumed 170.90 247.81 255.12 311.20 255.84
Manufacturing expenses 27.88 28.50 25.59 22.90 16.12
Personnel expenses 40.59 39.07 34.61 37.25 29.88
Selling expenses 1.59 1.28 1.36 2.44 0.61
Adminstrative expenses 41.46 34.54 30.06 28.22 24.39
Expenses capitalised - - - - -
Cost of sales 282.43 351.20 346.73 402.01 326.84
Operating profit 35.80 17.39 25.52 49.05 53.30
Other recurring income 0.50 0.10 0.44 0.09 4.72
Adjusted PBDIT 36.30 17.49 25.95 49.14 58.02
Financial expenses 14.93 13.92 12.75 11.16 9.33
Depreciation 16.38 14.63 10.99 10.25 9.18
Other write offs - - - - -
Adjusted PBT 4.99 -11.06 2.21 27.73 39.52
Tax charges -1.93 -2.01 0.94 8.08 11.55
Adjusted PAT 6.92 -9.05 1.27 19.66 27.97
Non recurring items -0.62 -0.56 - - -
Other non cash adjustments - - - - -
Reported net profit 6.31 -9.61 1.27 19.66 27.97
Earnigs before appropriation 99.66 93.35 103.26 101.99 82.51
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 99.66 93.35 103.26 101.99 82.51
Close
Add Mangalam Drugs and Organics Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Mangalam Drugs and Organics Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback